Lasa Supergenerics Stock Hits 52-Week Low, Given 'Strong Sell' Rating by MarketsMOJO

Lasa Supergenerics, a microcap pharmaceutical company, has recently seen a dip in its stock price, hitting a 52-week low on June 5th, 2024. According to MarketsMOJO, the stock has been given a 'Strong Sell' rating.

The stock's performance today has underperformed the sector by -4.83%, with a new 52-week low of Rs.19.16. This marks a consecutive 10-day fall for the stock, with a -18.19% return in that period. Additionally, Lasa Supergenerics is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the Sensex, Lasa Supergenerics has seen a -20.56% performance in the past year, while the Sensex has seen a 15.55% performance.

While the stock's current performance may be concerning, it is important to note that this is not a reflection of the company's potential or the overall pharmaceutical industry. As a microcap company, Lasa Supergenerics may experience more volatility in its stock price. Investors should carefully consider their options and do their own research before making any decisions.